Cambridge-based online patient community business PatientsLikeMe is teaming up with Boston-area health system Partners HealthCare to provide information and insights from PLM's platform to Partners' patients.
“We’re excited to work with such an esteemed health system to help patients and their care teams have a more complete understanding of patients’ whole health experience, and to support...
Swedish clinical trial recruitment company Trialbee has raised $5 million in first-round funding from existing investors Industrifonden and Briban Invest. The company previously raised about $3.2 million in seed funding. The money will be used, among other things, to support Trialbee's entrance into the US market.
Trialbee provides mobile and web-based tools for clinical trial recruitment, online...
Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen.
The PatientsLikeMe-AstraZeneca deal is similar to one the company struck with Genentech last Spring. AstraZeneca will have full access to PatientsLikeMe's...
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round.
The Nottingham, England-based company...
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies.
According to R2G, the top pharma companies have 65 apps in the Apple and...
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD.
The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
A screenshot from Exco's clinical trial software.
One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD) in the UK using mobile and online tools....
Without a doubt the number of digital health startups has grown considerably these past few years and many more larger companies have dedicated teams or business units focused on digital health. With that kind of growth comes job opportunities. As it happens, in recent weeks a few digital health hires and departures caught my attention.
Julie Kling, who has served as the mobile executive business...
Mobile only households continue to rise: Surprise, surprise! Mobile only households continue to rise as use of landline phones declines. Preliminary results from the January-June 2010 National Health Interview Survey (NHIS) indicate that more than one of every four American homes (26.6 percent) had only mobile phones. The survey includes data current as of the first half of 2010. It marks an...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
